What is King Pharmaceuticals's accrued interest?

King Pharmaceuticals (KG) reported accrued interest of $644K in Q1 2026.

What does accrued interest mean?

Interest expense accrued but not yet paid on outstanding debt obligations, based on contractual interest rates and time elapsed.

King Pharmaceuticals KG Accrued interest

Accrued interest at other companies

Everest GroupEG

$42M-2.3%

Greenlight Capital RE, Ltd.GLRE

$0-100%

Kearny FinancialKRNY

$28.3M-0.8%

KemperKMPR

$71.1M+3.6%

Community Financial SystemCBU

$56.56M+5.6%

LazardLAZ

$57.03M+0.8%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InterestReceivable.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's accrued interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's accrued interest?: King Pharmaceuticals (KG) reported accrued interest of $644K in Q1 2026.
What does accrued interest mean?: Interest expense accrued but not yet paid on outstanding debt obligations, based on contractual interest rates and time elapsed.